Medios AG MEDOF OTC · Healthcare · Germany
$50.00 +0.00% +$0.00
Summary
41 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It has been profitable 6 years in a row.
What to watch
- Out of every 100 EUR of revenue, only 0.5 EUR is left as net profit.
- Revenue growth is slowing: 8.9% a year over the last 3 years against 27% over 5 years.
- It missed profit estimates 5 times in the last 6 quarters.
- It earns only 2.4 EUR a year on every 100 EUR of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 103.9 EUR for 1 EUR of yearly profit. Over the last five years it was 81.1 EUR on average.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 27% a year over 5 years. Over the last 3 years it grew by 8.9% a year. Earnings per share fell by 7.4% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 EUR of revenue goes
- Cost of sales 91 EUR
- Sales and administration 7.5 EUR
- Taxes and other 1.4 EUR
- Net profit 0.5 EUR
Net profit, industry median (Medical - Distribution) 1.4 EUR
Out of every 100 EUR of revenue, 0.5 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.3 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.